Streptococcus adhesion antigen GAPDH and preparation method thereof
A streptococcus and adhesion technology, applied in the field of streptococcus adhesion antigen GAPDH and its preparation, can solve the problem of difficult to effectively control SEZ infection and other problems, and achieve the effect of weakening ability and weakening ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment one, bacterial strain and growth condition
[0026] The bacterial strain adopts SEZ C55138 strain; the medium is TSB medium or TSA medium containing 5% fetal bovine serum; shake culture at 37° C. for about 8 hours, or the OD600 reaches 0.6-1.0.
[0027] The carrier is Escherichia coli pET-28a, and the competent cell is Escherichia coli BL21.
[0028] SEZ C55138 strain, pET-28a vector and Escherichia coli BL21 competent cells are all commercial products.
Embodiment 2
[0029] Embodiment two, preparation method
[0030] The GAPDH recombinant protein is encoded by the gapdh gene, the forward primer of the gapdh gene has a BamHI restriction site, and the reverse primer has an EcoRI restriction site. The forward and reverse primers were designed from the genome sequence of the NCBI database (Genbank CP001129.1).
[0031] The preparation method of Streptococcus equi subspecies zooepidemic protective antigen GAPDH comprises the following steps:
[0032] PCR amplification: use the genome of C55138 as a template, and use the following primers for PCR amplification;
[0033] Forward primer (SEQ ID NO.3): 5'-TCTT GGATCC CGTCTTATCC-3' (the underlined part is the BamHI restriction site),
[0034] Reverse primer (SEQ ID NO.4): 5'-CATTTCGTT GAATTC CCAT-3' (the underlined part is the EcoRI restriction site);
[0035] Ligation with the vector: the PCR product was digested with a restriction enzyme and then ligated with the pET-28a vector digested wit...
Embodiment 3
[0046] Embodiment 3. Mice immunization and challenge test
[0047] 1. Twenty 4-week-old BALB / c female mice were randomly divided into 2 groups, 10 in each group;
[0048] 2. Experimental group: After 50 μg of purified rGAPDH was emulsified with Freund's complete adjuvant, the mice in group 1 were immunized by intraperitoneal injection. After 14 days, the same antigen was emulsified with Freund's incomplete adjuvant, and the second injection was immunized in the same way. mice;
[0049] 3. Control group: inject PBS emulsified with Freund's complete adjuvant and incomplete adjuvant to the mice of the second group as a control;
[0050] 4. After all mice were immunized for 10 days, blood was obtained from the tail vein to obtain serum, and then SEZ C55138 strain (2×10 5 CFU / mL) challenge;
[0051] 5. Observe and record the growth of all mice.
[0052] Experimental results: The mouse serum was collected 10 days after the second immunization with rGAPDH, and the antibody titer ...
PUM
Property | Measurement | Unit |
---|---|---|
molecular weight | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com